Work

Reply: Letter to the Editor Regarding “Autologous Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis”

Year: 2019

Type: letter

Abstract: Systemic sclerosis (SSc) is a heterogeneous disease with a pervasive impact on quality of life and high rates of associated morbidity and mortality. Three randomized controlled trials (RCTs) and a retrospective study have suggested that autologous stem cell transplantation (ASCT) is an effective treatment modality for this devastating disease [1–4]. We have previously performed a meta-analysis to provide a pooled estimate of trials comparing ASCT and standard treatment in patients with severe SSc [5].

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2018.12.837

Authors: Roni Shouval, Nadav Furie, Pia Raanani, Arnon Nagler, Anat Gafter-Gvili

Institutions: Tel Aviv University, Sheba Medical Center, Rabin Medical Center

Language: English

Topic: Systemic Sclerosis and Related Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W2908826546

Cites: 6

Cited by:

Related to: 10